Primary Site >> Liver Cancer

Gene >> SLC29A1

Journal: Pharmacology. 2015;96(3-4):163-6.
Title: ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors.
Author: Lombardi, Andrea|Landonio, Simona|Magni, Carlo|Cheli, Stefania|Mazzali, Cristina|Mondelli, Mario U|Rizzardini, Giuliano|Clementi, Emilio|Falvella, Felicia Stefania
PMID: 26279293
Journal: Mol Imaging Biol. 2017 Aug;19(4):540-549.
Title: Response Monitoring with [(18)F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases.
Author: Heskamp, Sandra|Heijmen, Linda|Gerrits, Danny|Molkenboer-Kuenen, Janneke D M|Ter Voert, Edwin G W|Heinzmann, Kathrin|Honess, Davina J|Smith, Donna-Michelle|Griffiths, John R|Doblas, Sabrina|Sinkus, Ralph|Laverman, Peter|Oyen, Wim J G|Heerschap, Arend|Boer
PMID: 27798786
Journal: Am J Cancer Res. 2017 Dec 1;7(12):2465-2477. eCollection 2017.
Title: Low SLC29A1 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
Author: Gao, Ping-Ting|Cheng, Jian-Wen|Gong, Zi-Jun|Hu, Bo|Sun, Yun-Fan|Cao, Ya|Qiu, Shuang-Jian|Zhou, Jian|Fan, Jia|Yang, Xin-Rong
PMID: 29312800